Click for best price
Krabbe Disease Drugs Market Size, Share 2023
Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to make myelin in a human body.
This report aims to provide a comprehensive presentation of the global market for Krabbe Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Krabbe Disease Drugs. This report contains market size and forecasts of Krabbe Disease Drugs in global, including the following market information:
Global Krabbe Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Krabbe Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Globally North America is the largest market for Krabbe disease treatment. Europe is the second-largest market and Asia Pacific is expected to grow at a fastest rate.
We surveyed the Krabbe Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Krabbe Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Krabbe Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Anticonvulsants
Muscle Relaxants
Others
Global Krabbe Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Krabbe Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Centers
Others
Global Krabbe Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Krabbe Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Krabbe Disease Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Krabbe Disease Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Takeda
UCB Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Krabbe Disease Drugs, market overview.
Chapter 2: Global Krabbe Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Krabbe Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Krabbe Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Krabbe Disease Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Krabbe Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Krabbe Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Krabbe Disease Drugs Overall Market Size
2.1 Global Krabbe Disease Drugs Market Size: 2022 VS 2029
2.2 Global Krabbe Disease Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Krabbe Disease Drugs Players in Global Market
3.2 Top Global Krabbe Disease Drugs Companies Ranked by Revenue
3.3 Global Krabbe Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Krabbe Disease Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Krabbe Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Krabbe Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Krabbe Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Krabbe Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Krabbe Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 Anticonvulsants
4.1.3 Muscle Relaxants
4.1.4 Others
4.2 By Type - Global Krabbe Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Krabbe Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Krabbe Disease Drugs Revenue, 2024-2029
4.2.3 By Type - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Krabbe Disease Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Centers
5.1.5 Others
5.2 By Application - Global Krabbe Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Krabbe Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Krabbe Disease Drugs Revenue, 2024-2029
5.2.3 By Application - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Krabbe Disease Drugs Market Size, 2022 & 2029
6.2 By Region - Global Krabbe Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Krabbe Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Krabbe Disease Drugs Revenue, 2024-2029
6.2.3 By Region - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Krabbe Disease Drugs Revenue, 2018-2029
6.3.2 US Krabbe Disease Drugs Market Size, 2018-2029
6.3.3 Canada Krabbe Disease Drugs Market Size, 2018-2029
6.3.4 Mexico Krabbe Disease Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Krabbe Disease Drugs Revenue, 2018-2029
6.4.2 Germany Krabbe Disease Drugs Market Size, 2018-2029
6.4.3 France Krabbe Disease Drugs Market Size, 2018-2029
6.4.4 U.K. Krabbe Disease Drugs Market Size, 2018-2029
6.4.5 Italy Krabbe Disease Drugs Market Size, 2018-2029
6.4.6 Russia Krabbe Disease Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Krabbe Disease Drugs Market Size, 2018-2029
6.4.8 Benelux Krabbe Disease Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Krabbe Disease Drugs Revenue, 2018-2029
6.5.2 China Krabbe Disease Drugs Market Size, 2018-2029
6.5.3 Japan Krabbe Disease Drugs Market Size, 2018-2029
6.5.4 South Korea Krabbe Disease Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Krabbe Disease Drugs Market Size, 2018-2029
6.5.6 India Krabbe Disease Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Krabbe Disease Drugs Revenue, 2018-2029
6.6.2 Brazil Krabbe Disease Drugs Market Size, 2018-2029
6.6.3 Argentina Krabbe Disease Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Krabbe Disease Drugs Revenue, 2018-2029
6.7.2 Turkey Krabbe Disease Drugs Market Size, 2018-2029
6.7.3 Israel Krabbe Disease Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Krabbe Disease Drugs Market Size, 2018-2029
6.7.5 UAE Krabbe Disease Drugs Market Size, 2018-2029
7 Krabbe Disease Drugs Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Krabbe Disease Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Krabbe Disease Drugs Major Product Offerings
7.2.4 Johnson & Johnson Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Krabbe Disease Drugs Major Product Offerings
7.3.4 Novartis Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Krabbe Disease Drugs Major Product Offerings
7.4.4 Pfizer Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Krabbe Disease Drugs Major Product Offerings
7.5.4 Sanofi Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Company Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Krabbe Disease Drugs Major Product Offerings
7.6.4 Abbott Laboratories Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.6.5 Abbott Laboratories Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Krabbe Disease Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Krabbe Disease Drugs Major Product Offerings
7.8.4 Takeda Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 UCB Pharmaceuticals
7.9.1 UCB Pharmaceuticals Company Summary
7.9.2 UCB Pharmaceuticals Business Overview
7.9.3 UCB Pharmaceuticals Krabbe Disease Drugs Major Product Offerings
7.9.4 UCB Pharmaceuticals Krabbe Disease Drugs Revenue in Global Market (2018-2023)
7.9.5 UCB Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Krabbe Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Krabbe Disease Drugs Market Drivers in Global Market
Table 3. Krabbe Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Krabbe Disease Drugs in Global Market
Table 5. Top Krabbe Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Krabbe Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Krabbe Disease Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Krabbe Disease Drugs Product Type
Table 9. List of Global Tier 1 Krabbe Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Krabbe Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Krabbe Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Krabbe Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Krabbe Disease Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Krabbe Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Krabbe Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Krabbe Disease Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Krabbe Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Krabbe Disease Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Krabbe Disease Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Krabbe Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Krabbe Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Krabbe Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Krabbe Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Krabbe Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Krabbe Disease Drugs Product Offerings
Table 32. GlaxoSmithKline Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Krabbe Disease Drugs Product Offerings
Table 36. Johnson & Johnson Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Krabbe Disease Drugs Product Offerings
Table 40. Novartis Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Krabbe Disease Drugs Product Offerings
Table 44. Pfizer Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Krabbe Disease Drugs Product Offerings
Table 48. Sanofi Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Abbott Laboratories Company Summary
Table 51. Abbott Laboratories Krabbe Disease Drugs Product Offerings
Table 52. Abbott Laboratories Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Abbott Laboratories Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Krabbe Disease Drugs Product Offerings
Table 56. Teva Pharmaceutical Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceutical Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Krabbe Disease Drugs Product Offerings
Table 60. Takeda Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. UCB Pharmaceuticals Company Summary
Table 63. UCB Pharmaceuticals Krabbe Disease Drugs Product Offerings
Table 64. UCB Pharmaceuticals Krabbe Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. UCB Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Krabbe Disease Drugs Segment by Type in 2022
Figure 2. Krabbe Disease Drugs Segment by Application in 2022
Figure 3. Global Krabbe Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Krabbe Disease Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Krabbe Disease Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Krabbe Disease Drugs Revenue in 2022
Figure 8. By Type - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Krabbe Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Krabbe Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 16. US Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 28. China Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Krabbe Disease Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Krabbe Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbott Laboratories Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceutical Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. UCB Pharmaceuticals Krabbe Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
